Clotting Medication - Sport Style

NEW ORLEANS, Feb. 5, 2026 — An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic (clot-caused) stroke without raising bleeding concerns, ... An investigational anti-clotting medication, asundexian, demonstrated a reduction in the risk of a second ischemic (clot-caused) stroke without raising bleeding concerns, according to a preliminary ...

News Medical: Extended use of anti-clotting drugs reduces risk of recurrent blood clots Extending anti-clotting drugs beyond the initial treatment period of at least 90 days after a first blood clot is linked to lower rates of new clots developing compared with stopping treatment, finds ... EurekAlert!: New medication may reduce chances of a second clot-caused stroke without bleeding risk New medication may reduce chances of a second clot-caused stroke without bleeding risk Tom Parsons, 32, died in East Surrey Hospital after not being given anti-clotting medicine. News Medical: Investigational anti-clotting drug reduces risk of second ischemic stroke without bleeding concerns